This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984
Title: Alan S Kirschner: Innovator in Interferon Technology
Introduction
Alan S Kirschner is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of medical formulations. His innovative work has led to the creation of a patented product that enhances therapeutic options for patients.
Latest Patents
Alan S Kirschner holds a patent for an interferon kit. This kit is designed for preparing a lyophilized alpha interferon gel formulation suitable for topical administration. This invention represents a significant advancement in the delivery of interferon therapies, providing a more effective method for treatment.
Career Highlights
Kirschner has had a successful career at Schering Corporation, where he has been involved in various research and development projects. His work has focused on improving drug formulations and enhancing patient care through innovative solutions. His dedication to advancing medical technology has made a lasting impact in the field.
Collaborations
Throughout his career, Alan has collaborated with talented professionals, including Michael A Zupon and Joel A Sequeira. These partnerships have fostered a creative environment that has led to the development of groundbreaking medical products.
Conclusion
Alan S Kirschner's contributions to the field of biotechnology, particularly through his patented interferon kit, highlight his role as an innovator. His work continues to influence the development of effective medical treatments, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
